Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy

Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and molecular features. This study retrospectively investigated the clinical impact of G‐banding‐defined chromosomal abnormality on treatment ou...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Mizuno, Yoshimi, Tsukamoto, Taku, Kawata, Eri, Uoshima, Nobuhiko, Uchiyama, Hitoji, Yokota, Isao, Maegawa, Saori, Takimoto, Tomoko, Tanba, Kazuna, Matsumura‐Kimoto, Yayoi, Kuwahara‐Ota, Saeko, Fujibayashi, Yuto, Yamamoto‐Sugitani, Mio, Chinen, Yoshiaki, Shimura, Yuji, Horiike, Shigeo, Taniwaki, Masafumi, Kobayashi, Tsutomu, Kuroda, Junya
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852349/
https://ncbi.nlm.nih.gov/pubmed/29473332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1342
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items